PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease
Summary Keywords gut microbiome, intermittent fasting, metabolome, caloric restriction, obesity, weight loss, gastrointestinal symptoms, protein pacing Citation Mohr AE, Jasbi P, Bowes DA, Dirks B, Whisner CM, Arciero KM, Poe M, Gu H, Gumpricht E, Sweazea KL and Arciero PJ (2022) Exploratory analysis of one versus two-day intermittent fasting protocols on the gut microbiome and plasma metabolome in adults with overweight/obesity
The PC/DC is typically made by a FDA-registered 503a or 503b facility.
The mechanism of action includes several key effects: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels Suppressing glucagon release , thereby reducing glucose production by the liver Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake Most GLP-1 medications are administered via subcutaneous injection , either once weekly (semaglutide, dulaglutide) or once daily (liraglutide), depending on the specific formulation
